Zeitschrift für genetische Syndrome und Gentherapie
Offener Zugang

Abstrakt

Adenoviral Vectors for Hemophilia Gene Therapy

Brunetti-Pierri N and Philip Ng

Hemophilia is an inherited blood clotting disorder resulting from deficiency of blood coagulation factors. Current standard of care for hemophilia patients is frequent intravenous infusions of the missing coagulation factor. Gene therapy for hemophilia involves the introduction of a normal copy of the deficient coagulation factor gene thereby potentially offering a definitive cure for the bleeding disorder. A variety of approaches have been pursued for hemophilia gene therapy and this review article focuses on those that use adenoviral vectors.